发明名称 |
COMPOSITION COMPRISING METFORMIN AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING INFLAMMATORY BOWEL DISEASE |
摘要 |
The present invention relates to a composition comprising metformin as an active ingredient for preventing or treating inflammatory bowel disease. The metformin compound or the metformin-etanercept (product name: Enbrel) composite according to the present invention may have excellent effects of maintaining the thickness of the small intestine and length of the large intestine normal, inhibiting or decreasing the activity of IL-17 and TNF-a, and promoting or increasing the activity of IFNr, and therefore can be effectively used as a pharmaceutical composition for preventing or treating autoimmune diseases including inflammatory bowel disease. |
申请公布号 |
US2015196511(A1) |
申请公布日期 |
2015.07.16 |
申请号 |
US201514663235 |
申请日期 |
2015.03.19 |
申请人 |
CATHOLIC UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION |
发明人 |
Cho Mi-La;Lee Seon-Yeong;Yang Eun-Ji;Son Hye-Jin;Kim Eun-Kyung;Ryu Jun-Geol |
分类号 |
A61K31/155;A61K39/395 |
主分类号 |
A61K31/155 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for treating inflammatory bowel disease, the method comprising administering a composition comprising Metformin compound represented by the following Chemical Formula 1 or a pharmaceutically acceptable salt thereof to a subject in need thereof: |
地址 |
Seoul KR |